Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

A Critical Analysis Of China’s Health Reform

This article was originally published in PharmAsia News

Executive Summary

2008 will see the introduction of China's new health reform and policies. This editorial gives an overview of the woes plaguing the health care system such as low medical manpower and resources versus high user demand, poor medical facilities and distribution networks in rural areas, and escalating personal expenses. Also highlighted are adverse policies and a lack of proper standards for medical administration, private hospitals, retail market, health insurance schemes, and inconsistent controls that challenge the whole medical infrastructure. A summary of the previous health care system's adjustments and proposed drafts since the start of China's reform is provided to show the government's attempts to address these pressing issues. (Click here for more)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC066783

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel